3,5-Dimethylpyrazole | CAS:67-51-6

We serve 3,5-Dimethylpyrazole CAS:67-51-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,5-Dimethylpyrazole

Chemical Name:3,5-Dimethylpyrazole
CAS.NO:67-51-6
Synonyms:3,5-Dimethylpyrazole
3,5-dimethyl-1H-pyrazole
1H-Pyrazole, 3,5-dimethyl-
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 218.0±0.0 °C at 760 mmHg
Melting Point 105-108 °C(lit.)
Molecular Formula C5H8N2
Molecular Weight 96.130
Flash Point 90.5±11.7 °C
 
Specification:
Appearance:White crystalline powder
Assay(GC):≥99.0%
Moisture:≤0.1%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 3,5-Dimethylpyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrazole, 3,5-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-dimethyl-1H-pyrazole Use and application,3,5-dimethyl-1H-pyrazole technical grade,usp/ep/jp grade.


Related News: It also said it would bar South Koreans from visiting China as tourists.2,3-dichloro-5-fluoropyridine manufacturer In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.N-(2,6-Dimethylphenyl)chloroacetamide supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.2,6-Dihydroxybenzoic acid vendor But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.